top of page

PNEUMONIX MEDICAL ENDORSED BY JOHNS HOPKINS LUNG CANCER SCREENING INITIATIVE

PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development Corporation of Maryland about their technology and its ability to increase access to lung cancer screening. The successful large-animal data which was acquired with grant funding has gathered interest from physicians and public health officials about its ability to reduce costs and complications during the lung cancer screening process. Additionally, the results have fast-tracked them for further grant funding.

2 views0 comments

Recent Posts

See All

PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced that it received Phase I SBIR grants from the NSF. The awards w

bottom of page